• Home
  • Study Details
By physician referral or invitation only

A prospective observational clinical cohort study to assess the safety and efficacy of standard of care risk-adjusted pediatric Burkitt lymphoma treatment incorporating high-dose Methotrexate in Malawi

The purpose of the study is to address the lack of sufficient observational data related to lymphoma in Malawi and therefore by doing this to serve as a foundation for developing optimal treatment strategies that would be of more benefits in the treatment of Children, Adolescent and young adults with Burkitt lymphoma.

Age & Gender

  • 1 years ~ 17 years
  • Male, Female, Gender Inclusive

Contact the Team

Location

Thank you for your interest, but this study is recruiting by invitation only.

International (Malawi)

Additional Study Information

Principal Investigator

Kate Westmoreland
Pediatrics - Hematology/Oncology

Study Type

Clinical or Medical
Observational

Study Topics

Cancer (Pediatric Cancers, Lymphoma)
Child and Teen Health

IRB Number

21-1320

Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research